Prospective, Randomized Cross-Over Trial to Assess the Ability of a Dry-Powder Inhaler to Reverse the Local Side Effects of Pressurized Metered-Dose Inhalers

References

• Inhaler devices for asthma. Drug Ther Bull 2000; 38: 9–14
   PubMedGoogle Scholar
• Bhalla R K, Jones A S, Roland N J. Prevalence of pharyngeal and laryngeal complications in adult asthmatics using inhaled corticosteroids. J Laryngol Otol 2008; 1–6, Jan 18 [Epub ahead of print]
   PubMedGoogle Scholar
• Bhalla R K, Watson G, Taylor W, Jones A S, Roland N J. Acoustic analysis in asthmatics and the influence of inhaled corticosteroid therapy. J Voice 2008, Mar 15 [Epub ahead of print]
   PubMedGoogle Scholar
• Toogood J H, Jennings B, Greenway R W, Chuang L. Candidiasis and dysphonia complicating beclomethasone treatment of asthma. J Allergy Clin Immunol 1980; 65: 145–153
   PubMed Web of Science ®Google Scholar
• Hanania N A, Chapman K R, Kesten S. Adverse effects of inhaled corticosteroids. Am J Med 1995; 98: 196–208
   PubMed Web of Science ®Google Scholar
• Barnes P J, Pedersen S, Busse W. Efficacy and safety of inhaled corticosteroids. Am J Respir Crit Care Med 1998; 157: S1–53
   Google Scholar
• Local adverse effects of ICS. Expert panel report 3: Guidelines for the diagnosis and management of asthma. National Institutes of Health. 2007; 244, Full Report
   Google Scholar
• Fabbri L, Burge P S, Croonenborgh L, Warlies F, Weeke B, Ciaccia A, Parker C. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. Thorax 1993; 48: 817–823
   PubMed Web of Science ®Google Scholar
• Ayres J G, Lundback B, Harris T A. High dose fluticasone propionate, 1mg daily, versus fluticasone propionate, 2mg daily, or budesonide, 1.6mg daily, in patients with chronic severe asthma. International Study Group. Eur Resp J 1995; 8: 579–586
   PubMed Web of Science ®Google Scholar
• Pauwels R A, Hargreave F E, Camus P, Bukoski M, Stahl E. A 1-year comparison of Turbuhaler versus pressurised metered-dose inhaler in asthmatic patients. Chest 1996; 110: 53–57
   PubMedGoogle Scholar
• Brocklebank D, Wright J, Cates C. Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma. Br Med J 2001; 323: 896–900
   PubMed Web of Science ®Google Scholar
• Sharpe M, Jarvis B. Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma. Drugs 2001; 61: 1544
   Google Scholar
• Pedersen S, Hansen O R, Fuglsang G. Influence of inspiratory flow rate upon the effect of a Turbohaler. Arch Dis Child 1990; 65: 308–319
   PubMed Web of Science ®Google Scholar
• Selroos O, Backman R, Forsen K O, Lofroos A B, Niemisto M, Pietinalho A, Aikas C, Riska H. Local side effects during 4-year treatment with inhaled corticosteroids–a comparison between pressurised metered-dose inhalers and Turbohaler. Allergy 1994; 49: 888–890
   PubMedGoogle Scholar
• Lipworth B J. New perspectives on inhaled drug delivery and systemic bioactivity. Thorax 1995; 50: 105–110
   PubMedGoogle Scholar
• Webb A L, Carding P N, Deary I J, MacKenzie K, Steen N, Wilson J A. Optimising outcome assessment of voice interventions, I: reliability and validity of three self-reported scales. J Laryngol Otol 2007; 121: 763–767
   PubMed Web of Science ®Google Scholar
• European Union Directive. Official J Eur Communities 2001; 34–44, Directive 2001/20/EC – L121
   Google Scholar
• Toogood J H, Jennings B, Baskerville J, Anderson J, Johansson S A. Dosing regimen of budesonide and occurrence of oropharyngeal complications. Eur J Respir Dis 1984; 65: 35–44
   PubMedGoogle Scholar
• Lavy J A, Wood G, Rubin J S, Harries M. Dysphonia associated with inhaled steroids. J Voice 2000; 14: 581–588
   PubMed Web of Science ®Google Scholar
• Mirza N, Kasper Schwartz S, Antin-Ozerkis D. Laryngeal findings in users of combination corticosteroid and bronchodilator therapy. Laryngoscope 2004; 114: 1566–1599
   PubMed Web of Science ®Google Scholar
• Roland N J, Bhalla R K, Earis J. The local side effects of inhaled corticosteroids: current understanding and review of the literature. Chest 2004; 126: 213–219
   PubMed Web of Science ®Google Scholar
• Ihre E, Zetterstrom O, Hammarberg B. Voice problems as side effects of inhaled corticosteroids in asthma patients–a prevalence study. J Voice 2004; 18: 403–414
   PubMed Web of Science ®Google Scholar
• Gallivan G J, Gallivan K H, Gallivan H K. Inhaled corticosteroids: hazardous effects on voice–an update. J Voice 2007; 21: 101–111
   PubMed Web of Science ®Google Scholar
• Newman S P, Pavia D, Moren F, Sheahan N F, Clarke S W. Deposition of pressurised aerosols in the human respiratory tract. Thorax 1981; 36: 52–55
   PubMed Web of Science ®Google Scholar
• Newman S P, Weisz A WB, Talaee N, Clarke S W. Improvement of drug delivery with a breath-actuated pressurised aerosol for patients with poor inhaler technique. Thorax 1991; 46: 712–716
   PubMed Web of Science ®Google Scholar
• Hendry A, Coote J, Black H, Duncan G, MacDonald J B. Comparison of conventional metered-dose inhaler and breath-actuated inhaler in elderly patients. Int J Pharm Prac 1995; 3: 115–118
   Google Scholar
• Allen S C. Competence thresholds for the use of inhalers in people with dementia. Age Ageing 1997; 26: 83–86
   PubMed Web of Science ®Google Scholar
• Pedersen S, Frost L, Arnfred T. Errors in inhalation technique and efficiency in inhaler use in asthmatic children. Allergy 1986; 41: 118–124
   PubMed Web of Science ®Google Scholar
• Yokoyama H, Nakajima Y, Yamamura Y, Iga T, Yamada Y. Investigation of mouth washing by patients after inhaling corticosteroids. Yakugaku Zasshi 2005; 125: 455–461
   PubMedGoogle Scholar